Total debt fell to $743.4M against $775.0M of equity, reducing debt-to-equity to 0.96 from 1.57 in 2025Q2, though goodwill of $759.0M remains a large share of $2.3B total assets.
AMN Healthcare Services, Inc. (AMN) balance sheet — 26-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 |
|---|
| Total Current Assets | 803.73M | 545.38M | 594.91M | 841.68M | 1.09B | 1.35B | 533.74M | 560.5M | 482.17M | 474.15M | 450.63M | 375.63M | 282.67M | 230.1M | 203.74M | 212.47M | 179.26M | 137.44M | 229.83M | 242.95M | 235.85M | 228.26M | 127.41M | 137.94M | 188.65M | 151.94M | 68.76M |
| Cash & Short-Term Investments | 255.98M | 33.97M | 10.65M | 32.94M | 64.52M | 180.93M | 29.21M | 82.98M | 13.86M | 15.15M | 10.62M | 9.58M | 13.07M | 15.58M | 5.68M | 3.96M | 1.88M | 27.05M | 11.32M | 18.5M | 4.42M | 19.11M | 3.91M | 4.69M | 40.13M | 31.97M | 546K |
| Cash Only | 255.98M | 33.97M | 10.65M | 32.94M | 64.52M | 180.93M | 29.21M | 82.98M | 13.86M | 15.15M | 10.62M | 9.58M | 13.07M | 15.58M | 5.68M | 3.96M | 1.88M | 27.05M | 11.32M | 18.5M | 4.42M | 19.11M | 3.91M | 4.69M | 40.13M | 15.65M | 546K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.31M | 0 |
| Accounts Receivable | 460.47M | 439.11M | 519.98M | 746.54M | 953.25M | 1.03B | 450.08M | 431.38M | 416.81M | 407.41M | 391.57M | 332.49M | 218.22M | 168.83M | 161.31M | 172.52M | 148.31M | 93.4M | 186M | 184.74M | 192.72M | 163.24M | 108.83M | 117.39M | 134.46M | 110.22M | 63.4M |
| Days Sales Outstanding | 44.74 | 58.7 | 63.61 | 71.91 | 66.36 | 94.25 | 68.63 | 70.86 | 71.22 | 74.78 | 75.13 | 82.95 | 76.88 | 60.9 | 61.72 | 70.96 | 78.54 | 44.87 | 55.78 | 57.93 | 65.03 | 84.41 | 63.15 | 59.99 | 63.27 | 77.69 | 100.28 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 38.85M | 0 | 39.54M | 57.91M | 34.46M | 25.52M | 46.73M | 41.39M | 25.41M | 32.34M | 27.14M | 15.08M | 27.61M | 37.67M | 36.73M | 44.07M | 12.91M | 14.03M | 11.9M | 7.81M | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | 8.85 | - | 10.02 | 15.73 | 9.81 | 9.37 | 23.69 | 21.14 | 13.57 | 18.5 | 19.9 | 9.91 | 11.19 | 15.97 | 16.92 | 30.03 | 9.72 | 9.27 | 7.4 | 7.34 | - |
| Other Current Assets | 62.92M | 51.43M | 41.77M | 40.32M | 57.16M | 66.83M | 1.96M | 34.46M | -450K | -22.81M | -214K | 20.04M | 41.03M | 29.23M | 29.47M | 30.3M | 22.1M | 10.44M | 22.99M | 30.13M | 28.27M | 33.15M | 2.97M | 1.83M | 2.17M | 1.94M | 4.81M |
| Total Non-Current Assets | 1.49B | 1.55B | 1.82B | 2.08B | 1.79B | 1.78B | 1.82B | 1.37B | 1.01B | 779.8M | 736.25M | 504.8M | 399.25M | 362.13M | 313.64M | 323.16M | 382.85M | 251.57M | 412.99M | 390.68M | 386.33M | 390.12M | 159.56M | 166.59M | 160.12M | 156.99M | 140.65M |
| Property, Plant & Equipment | 134.89M | 136.36M | 218.38M | 225.93M | 165.54M | 154.88M | 193.91M | 194.7M | 90.42M | 73.43M | 59.95M | 50.13M | 32.88M | 21.16M | 14.81M | 16.86M | 21.78M | 19.97M | 24.02M | 24.6M | 23.24M | 20.16M | 17.83M | 18.41M | 9.87M | 7.71M | 5.01M |
| Fixed Asset Turnover | 26.04x | 20.02x | 13.66x | 16.77x | 31.67x | 25.72x | 12.34x | 11.41x | 23.62x | 27.08x | 31.73x | 29.18x | 31.51x | 47.82x | 64.39x | 52.63x | 31.65x | 38.05x | 50.68x | 47.32x | 46.55x | 35.01x | 35.27x | 38.79x | 78.60x | 67.13x | 46.10x |
| Goodwill | 759M | 755.81M | 897.46M | 1.11B | 935.36M | 892.34M | 864.49M | 595.55M | 438.51M | 340.6M | 341.75M | 204.78M | 154.39M | 144.64M | 123.32M | 123.32M | 154.18M | 79.87M | 252.88M | 241.27M | 240.72M | 240.84M | 135.45M | 0 | 0 | 0 | 0 |
| Intangible Assets | 233.81M | 283.53M | 381.36M | 474.13M | 476.83M | 514.46M | 564.91M | 398.47M | 326.15M | 227.1M | 245.72M | 174.97M | 152.52M | 150.2M | 136.91M | 143.57M | 165.58M | 115.34M | 122.84M | 113.53M | 116.39M | 121.15M | 82K | 140.47M | 136.73M | 129.25M | 124.98M |
| Long-Term Investments | 91.42M | 45.61M | 0 | 0 | 0 | 0 | 0 | 0 | -27.33M | -27.04M | -21.42M | -22.43M | -27.33M | -24.94M | 1.61M | 0 | 0 | 22.02M | -18.09M | -28.08M | -26.27M | -31.3M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 300.8M | 282.55M | 297.78M | 271.1M | 216.97M | 221.15M | 129.26M | 182.42M | 155.48M | 138.68M | 88.82M | 74.92M | 59.46M | 46.14M | 18.86M | 37.57M | 41.08M | 5.83M | 13.25M | 11.27M | 5.98M | 7.96M | 2.27M | 1.64M | 1.41M | 617K | 102K |
| Total Assets | 2.29B | 2.09B | 2.42B | 2.92B | 2.89B | 3.13B | 2.35B | 1.93B | 1.49B | 1.25B | 1.19B | 880.43M | 681.92M | 592.23M | 517.39M | 535.63M | 562.11M | 389M | 642.82M | 633.63M | 622.18M | 618.39M | 286.96M | 304.53M | 348.77M | 308.93M | 209.41M |
| Asset Turnover | 1.50x | 1.30x | 1.24x | 1.30x | 1.82x | 1.27x | 1.02x | 1.15x | 1.43x | 1.59x | 1.60x | 1.66x | 1.52x | 1.71x | 1.84x | 1.66x | 1.23x | 1.95x | 1.89x | 1.84x | 1.74x | 1.14x | 2.19x | 2.35x | 2.22x | 1.68x | 1.10x |
| Asset Growth % | 9.48% | -13.31% | -17.39% | 1.25% | -7.78% | 33.07% | 21.84% | 29.4% | 19.04% | 5.65% | 34.81% | 29.11% | 15.14% | 14.47% | -3.41% | -4.71% | 44.5% | -39.48% | 1.45% | 1.84% | 0.61% | 115.5% | -5.77% | -12.68% | 12.9% | 47.52% | - |
| Total Current Liabilities | 665.78M | 577.61M | 545.78M | 656.12M | 857.93M | 969.39M | 422.96M | 378.11M | 307.27M | 265.27M | 274.79M | 251.02M | 178.29M | 140.29M | 109.53M | 140.05M | 117.89M | 63.1M | 141.27M | 128.56M | 120.97M | 128.18M | 50.15M | 60.96M | 51.35M | 35.46M | 24.61M |
| Accounts Payable | 189.93M | 84.94M | 100.92M | 177.11M | 373.32M | 339.01M | 107.45M | 102.55M | 82.43M | 73.21M | 85.36M | 84.94M | 63.51M | 59.34M | 44.36M | 42.42M | 19.33M | 13.41M | 20.21M | 22.23M | 16.72M | 19.09M | 6.92M | 3.21M | 12.74M | 5.63M | 2.43M |
| Days Payables Outstanding | 24.11 | 15.85 | 17.84 | 25.45 | 38.64 | 46.26 | 24.48 | 25.31 | 20.9 | 19.88 | 24.29 | 31.2 | 32.2 | 30.31 | 23.69 | 24.27 | 14.17 | 8.81 | 8.2 | 9.43 | 7.7 | 13.01 | 5.21 | 2.12 | 7.92 | 5.29 | 5.2 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 4.69M | 0 | 0 | 0 | 3.75M | 37.5M | 25.5M | 10M | 0 | 35.29M | 19.01M | 5.5M | 50.77M | 26.62M | 23.25M | 10.25M | 5.96M | 13.4M | 1.23M | 1.64M | 8.06M |
| Deferred Revenue (Current) | 117.06M | 106.83M | 66.36M | 20.01M | 33.29M | 157.05M | 11M | 11.79M | 12.37M | 8.38M | 8.92M | 5.62M | 3.18M | 2.41M | 2.83M | 2.15M | 7.19M | 5.08M | 7.18M | 7.65M | 6.4M | 7.61M | 40.91M | 41.87M | 34.49M | 23.96M | 11.02M |
| Other Current Liabilities | 129.71M | 256.35M | 237.53M | 223.39M | 251.95M | 250.48M | 167.37M | 149.71M | 88.79M | 62.26M | 68.76M | 25.68M | 25.81M | 16.23M | 15.8M | -9.59M | 14.52M | 10.4M | 18.23M | 28.62M | 28.46M | 59.02M | 7.3M | 2.49M | 2.9M | 4.23M | 3.11M |
| Current Ratio | 1.21x | 0.94x | 1.09x | 1.28x | 1.27x | 1.39x | 1.26x | 1.48x | 1.57x | 1.79x | 1.64x | 1.50x | 1.59x | 1.64x | 1.86x | 1.52x | 1.52x | 2.18x | 1.63x | 1.89x | 1.95x | 1.78x | 2.54x | 2.26x | 3.67x | 4.28x | 2.79x |
| Quick Ratio | 1.21x | 0.94x | 1.09x | 1.28x | 1.27x | 1.39x | 1.17x | 1.48x | 1.44x | 1.57x | 1.51x | 1.39x | 1.32x | 1.35x | 1.63x | 1.29x | 1.29x | 1.94x | 1.43x | 1.60x | 1.65x | 1.44x | 2.28x | 2.03x | 3.44x | 4.06x | 2.79x |
| Cash Conversion Cycle | 20.62 | - | - | - | - | - | 53 | - | 60.35 | 70.63 | 60.65 | 61.12 | 68.37 | 51.74 | 51.6 | 65.19 | 84.27 | 45.97 | 58.77 | 64.47 | 74.24 | 101.43 | 67.66 | 67.15 | 62.75 | 79.75 | - |
| Total Non-Current Liabilities | 852.18M | 874.39M | 1.16B | 1.44B | 986.78M | 1B | 1.11B | 816.8M | 546.46M | 426.16M | 462.71M | 281.56M | 247.04M | 234.2M | 225.75M | 259.92M | 290.76M | 155.06M | 217.41M | 228.94M | 256.67M | 297.01M | 100.03M | 127.48M | 1.6M | 1.56M | 117.73M |
| Long-Term Debt | 743.37M | 767.05M | 1.06B | 1.3B | 843.5M | 842.32M | 857.96M | 617.16M | 440.61M | 319.84M | 359.19M | 180.99M | 136.88M | 148.67M | 158.18M | 174.2M | 200.81M | 100.12M | 100.24M | 120.35M | 160.48M | 194.75M | 96.86M | 125.5M | 0 | 0 | 115.39M |
| Capital Lease Obligations | 85.85M | 30.14M | 35.73M | 37.6M | 9.36M | 13.36M | 77.8M | 91.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 709K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 23.35M | 22.71M | 47.81M | 0 | 46.62M | 27.33M | 0 | 0 | 22.43M | 32.49M | 17.76M | 5.28M | 0 | 0 | 789K | 58.47M | 71.09M | 69.36M | 65.13M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 108.81M | 77.19M | 71.72M | 71.38M | 111.21M | 96.99M | 107.91M | 61.81M | 77.66M | 79.28M | 82.1M | 78.13M | 77.67M | 67.76M | 62.29M | 85.72M | 89.95M | 54.15M | 50.12M | 37.5M | 26.82M | 37.13M | 3.17M | 1.98M | 1.6M | 1.56M | 2.34M |
| Total Liabilities | 1.52B | 1.45B | 1.71B | 2.09B | 1.84B | 1.97B | 1.53B | 1.19B | 853.73M | 691.43M | 737.5M | 532.57M | 425.33M | 374.49M | 335.27M | 399.97M | 408.65M | 218.16M | 358.68M | 357.5M | 377.63M | 425.19M | 150.18M | 188.44M | 52.95M | 37.02M | 142.34M |
| Total Debt | 743.37M | 803.2M | 1.1B | 1.35B | 860.96M | 867.07M | 955.48M | 722.31M | 440.61M | 319.84M | 362.94M | 218.49M | 162.38M | 158.91M | 158.18M | 208.84M | 219.15M | 105.62M | 18.57M | 146.97M | 183.73M | 205M | 101.72M | 138.9M | 1.23M | 1.64M | 123.44M |
| Net Debt | 487.39M | 769.23M | 1.09B | 1.32B | 796.43M | 686.14M | 926.27M | 639.33M | 426.75M | 304.7M | 352.32M | 208.91M | 149.3M | 143.33M | 152.5M | 204.88M | 217.27M | 78.57M | 7.26M | 128.47M | 179.31M | 185.89M | 97.81M | 134.21M | -38.91M | -14.01M | 122.9M |
| Debt / Equity | 0.96x | 1.25x | 1.55x | 1.62x | 0.82x | 0.75x | 1.17x | 0.98x | 0.69x | 0.57x | 0.81x | 0.63x | 0.63x | 0.73x | 0.87x | 1.54x | 1.43x | 0.62x | 0.07x | 0.53x | 0.75x | 1.06x | 0.74x | 1.20x | 0.00x | 0.01x | 1.84x |
| Debt / EBITDA | 2.18x | 4.23x | 15.44x | 2.70x | 1.10x | 1.49x | 3.92x | 3.07x | 1.81x | 1.31x | 1.64x | 1.46x | 1.94x | 2.01x | 2.34x | 3.87x | - | - | 0.22x | 1.75x | 2.19x | 3.87x | 2.41x | 2.02x | 0.01x | 0.07x | 22.24x |
| Net Debt / EBITDA | 1.43x | 4.05x | 15.29x | 2.64x | 1.02x | 1.18x | 3.80x | 2.72x | 1.75x | 1.25x | 1.59x | 1.39x | 1.78x | 1.81x | 2.26x | 3.80x | - | - | 0.08x | 1.53x | 2.14x | 3.51x | 2.32x | 1.95x | -0.43x | -0.58x | 22.14x |
| Interest Coverage | 6.08x | -1.22x | -1.47x | 6.25x | 16.02x | 14.03x | 2.59x | 6.22x | 12.56x | 10.80x | 12.39x | 16.54x | 7.01x | 6.78x | 1.67x | 1.59x | -2.21x | -12.85x | 6.73x | 5.81x | 4.40x | 4.76x | 4.31x | 27.77x | - | - | - |
| Total Equity | 775.01M | 642.11M | 706.62M | 831.26M | 1.04B | 1.16B | 819.68M | 736.74M | 638.99M | 562.53M | 449.38M | 347.86M | 256.58M | 217.74M | 182.11M | 135.66M | 153.46M | 170.84M | 284.13M | 276.13M | 244.55M | 193.2M | 136.78M | 116.1M | 295.82M | 271.9M | 67.07M |
| Equity Growth % | 32.82% | -9.13% | -14.99% | -20.35% | -10.19% | 41.77% | 11.26% | 15.3% | 13.59% | 25.18% | 29.18% | 35.58% | 17.84% | 19.57% | 34.24% | -11.6% | -10.18% | -39.87% | 2.9% | 12.91% | 26.58% | 41.25% | 17.81% | -60.75% | 8.8% | 305.4% | - |
| Book Value per Share | 19.30 | 16.67 | 18.50 | 21.13 | 23.26 | 24.19 | 17.19 | 15.48 | 13.13 | 11.38 | 9.12 | 7.12 | 5.34 | 4.56 | 3.90 | 2.95 | 4.40 | 5.24 | 8.40 | 7.92 | 7.09 | 6.02 | 4.36 | 2.92 | 6.32 | 8.87 | 2.98 |
| Total Shareholders' Equity | 775.01M | 642.11M | 706.62M | 831.26M | 1.04B | 1.16B | 819.68M | 736.74M | 638.99M | 562.53M | 449.38M | 347.86M | 256.58M | 217.74M | 182.11M | 135.66M | 153.46M | 170.84M | 284.13M | 276.13M | 244.55M | 193.2M | 136.78M | 116.1M | 295.82M | 271.9M | 67.07M |
| Common Stock | 514K | 511K | 507K | 504K | 501K | 498K | 496K | 493K | 488K | 484K | 481K | 477K | 466K | 460K | 457K | 405K | 392K | 458K | 457K | 454K | 452K | 437K | 432K | 430K | 430K | 423K | 288K |
| Retained Earnings | 1.33B | 1.21B | 1.3B | 1.45B | 1.24B | 796.95M | 469.56M | 400.05M | 286.06M | 142.23M | 9.67M | -96.17M | -178.06M | -211.28M | -242.19M | -259.33M | -233.07M | -16.71M | 105.47M | 81.04M | 45.04M | 47.78M | 33.16M | 15.81M | -21.98M | -74.34M | -69.95M |
| Treasury Stock | -1.14B | -1.13B | -1.13B | -1.13B | -698.6M | -121.83M | -119.14M | -119.14M | -100.44M | -33.42M | -13.26M | 0 | 0 | 0 | 0 | 0 | 0 | -230.14M | -230.14M | -201.69M | -183.18M | -210.53M | -249.54M | -249.43M | -35.16M | 0 | 0 |
| Accumulated OCI | -354K | 298K | -11K | -423K | -939K | -295K | 40K | 152K | 151K | -112K | 1K | -183K | -356K | -498K | -443K | -373K | -421K | -457K | -2.08M | -907K | 142K | -254K | 271K | -309K | -7.06M | -1.76M | -1.76M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying AMN stock.
As of 2025, AMN Healthcare Services, Inc. (AMN) had total assets of $2.09B including $545.4M in current assets.
AMN Healthcare Services, Inc. (AMN) carries total debt of $803.2M, offset by $34.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
AMN Healthcare Services, Inc. (AMN) has total shareholders' equity (book value) of $642.1M ($16.67 book value per share). Book value represents the net worth of the company belonging to common stock holders.
AMN Healthcare Services, Inc. (AMN) reported a current ratio of 0.94x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Leverage tied to cyclical demand
Metrics are mathematically derived from official filings.
Deleveraging Driven by Shrinking Debt
According to reported quarterly figures, AMN's debt-to-equity ratio fell from 1.57 in 2025Q2 to 0.96 in 2026Q3, a gain driven mainly by debt reduction from roughly $956M to $743M rather than by equity expansion alone.
The improvement in leverage appears to reflect deliberate repayment of borrowings, which compresses the balance sheet while total assets have also contracted from about $2.4B to $2.3B. Equity has recovered from $607.6M to $775.0M, but retained earnings remain near $1.3B, suggesting the equity rebuild is partly tied to recent profitability rather than a sustained earnings base. Investors should monitor whether further deleveraging continues if revenue softness returns.
Leverage Eased but Remains Elevated
Based on EDBL-style reported figures, AMN's total debt of $743.4M against $775.0M of equity leaves a debt-to-equity ratio near 0.96, which is improved from prior quarters yet still meaningful for a business with negative trailing net margin.
A ratio near one indicates that borrowed capital still funds a substantial share of the business, and this matters because the company's earnings are currently thin with an operating margin of only 1.2% over the trailing period. Debt service obligations therefore consume a large portion of operating income, which may limit flexibility if hospital demand weakens again. Refinancing risk warrants monitoring given the cyclical nature of staffing revenue.
Cash Buffer Rebuilt From Thin Base
As reported in financial statements, AMN's cash rose to $256.0M in 2026Q3 from $34.0M at 2025Q4, while the current ratio improved to 1.21, indicating a buffer that was previously very limited.
The sharp rebuild in cash follows a period when the company held only tens of millions in liquidity against more than $1.5B of liabilities, which suggests management relied heavily on operating cash inflows and working capital timing. A current ratio above one provides modest short-term coverage, but the margin of safety is narrow relative to total liabilities. Cash balances may be sensitive to the timing of receivables collections as observed in recent swings.
Goodwill Anchors an Acquisition-Built Asset Base
According to recent SEC filings, AMN's goodwill of $759.0M represents roughly one-third of total assets, reflecting an asset base shaped largely by acquisitions rather than physical capital.
Net property, plant and equipment of only $134.9M confirms a light, asset-efficient staffing model, yet the large goodwill balance concentrates risk in acquired intangibles that could face impairment if segment performance deteriorates. The goodwill has already declined from $1.1B in 2024Q3, which may reflect prior impairment charges, and investors should treat the remaining balance as dependent on the durability of acquired revenue streams.
Equity Recovery Masks Thin Earnings Base
Based on reported figures, the equity rebound to $775.0M coincides with a trailing return on equity of negative 14.2%, suggesting the balance sheet improvement may be less durable than the headline book value implies.
Because retained earnings sit near $1.3B while recent net margins remain negative, the book value gain may partly reflect accounting movements or share count effects rather than sustained profit generation. Stock-based compensation layered on top of thin margins may further dilute economic value. The apparent strengthening should therefore be verified against cash generation before being treated as a durable improvement.